Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

クッシング病 (Cushing's disease) とは,クッシング病 (Cushing's disease) とは,クッシング病 (Cushing's disease) とは,クッシング病 (Cushing's disease)

P J Trainer, M Besser

    Lancet (London, England)
    |January 1, 2000
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Comparative analysis of biofilm models to determine the efficacy of antimicrobials.

    International journal of hygiene and environmental health·2021
    Same author

    Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care.

    Thrombosis research·2020
    Same author

    Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit.

    Journal of thrombosis and thrombolysis·2020
    Same author

    Heparin resistance in COVID-19 patients in the intensive care unit.

    Journal of thrombosis and thrombolysis·2020
    Same author

    Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom.

    Thrombosis research·2020
    Same author

    Efficacy of antiseptics in a novel 3-dimensional human plasma biofilm model (hpBIOM).

    Scientific reports·2020
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る